SEC10 Antibody

What is SEC10 protein and why is it significant in research?

SEC10 is a critical protein component of the mammalian exocyst complex, playing an essential role in the targeting of exocytic vesicles to specific docking sites on the plasma membrane. This process facilitates the secretion of proteins and other molecules, which is vital for numerous cellular functions including cell signaling, growth, and tissue repair . SEC10 functions as one of eight protein subunits that comprise the exocyst complex (along with Sec3, Sec5, Sec6, Sec8, Sec15, Exo70, and Exo84). In mouse and rat, SEC10 is referred to as the 71 kDa component of the rsec6/8 secretory complex, while in humans, the SEC10 gene is located on chromosome 14q22.3, highlighting its evolutionary conservation and importance across species . Research involving SEC10 antibodies is particularly valuable for studying vesicular trafficking, exocytosis mechanisms, and related cellular processes.

What types of SEC10 antibodies are available for research applications?

SEC10 antibodies are available in multiple formats to accommodate various experimental techniques. The primary type available is mouse monoclonal IgG2a kappa light chain antibody (such as the C-4 clone) that can detect SEC10 protein from mouse, rat, and human origins . Researchers can utilize both non-conjugated antibodies and various conjugated forms, including:

This diversity of formats allows researchers to select the most appropriate antibody preparation based on their specific experimental needs without additional labeling steps .

What are the validated experimental techniques compatible with SEC10 antibody?

SEC10 antibodies have been validated for multiple experimental techniques in protein research. The C-4 clone, for example, has been specifically validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), and enzyme-linked immunosorbent assay (ELISA) . When designing experiments, researchers should consider the following methodological considerations:

• Western Blotting: SEC10 antibody can detect the 77 kDa protein band in mammalian cell lysates, with optimal dilutions typically between 1:200 to 1:1000 depending on the specific antibody concentration and detection system.

• Immunoprecipitation: Agarose-conjugated formats are particularly useful for pulling down SEC10 protein and its binding partners.

• Immunofluorescence: Both unconjugated (with secondary antibody) or directly conjugated formats (FITC, PE, Alexa Fluor) can be utilized for cellular localization studies.

• ELISA: SEC10 antibody can be employed as a capture or detection antibody in sandwich ELISA systems for quantitative analysis.

When transitioning between techniques, researchers should validate the optimal antibody concentration for each application, as requirements may vary significantly.

How can SEC10 antibody be used to study exocyst complex dynamics and interactions?

SEC10 antibody serves as a powerful tool for investigating exocyst complex assembly, dynamics, and protein-protein interactions. For comprehensive analysis of the exocyst complex, researchers should consider these methodological approaches:

• Co-immunoprecipitation with SEC10 antibody: Using agarose-conjugated SEC10 antibody to pull down the entire exocyst complex, followed by western blotting for other components (Sec3, Sec5, Sec6, Sec8, Sec15, Exo70, and Exo84) to assess complex composition under different cellular conditions.

• Proximity ligation assays: Combining SEC10 antibody with antibodies against other exocyst components to visualize and quantify protein interactions in situ with single-molecule resolution.

• Sequential immunoprecipitation: For studying subcomplexes, particularly the known SEC10-SEC15 subcomplex, researchers can perform sequential IPs to identify specific interaction partners and their stoichiometry.

• FRAP (Fluorescence Recovery After Photobleaching): Using fluorescently-labeled SEC10 antibody fragments to study the dynamics of exocyst complex assembly and disassembly in live cells.

When designing these experiments, it's critical to include appropriate controls to distinguish between direct and indirect interactions within the complex. Additionally, researchers should consider using cell-permeable crosslinking agents before lysis to capture transient interactions that might be lost during standard immunoprecipitation procedures.

What are the critical chemical modifications that might affect SEC10 antibody performance?

Antibody chemical modifications can significantly impact binding affinity and experimental performance. From general antibody modification studies, researchers should be aware of several critical modifications that could affect SEC10 antibody functionality:

• Deamidation: This common modification can occur at asparagine residues, especially in CDR regions, potentially altering binding affinity when the Kd value exceeds 10⁻⁸ M .

• Oxidation: Methionine residues in antibodies are susceptible to oxidation, which can compromise structural integrity and binding capacity, especially in stress conditions.

• Isomerization: Aspartate residues can undergo isomerization to isoaspartate, which may affect antibody function, particularly in the complementarity-determining regions.

• Fragmentation: Heavy and light chain fragmentation can occur during storage or under stress conditions, reducing antibody efficacy.

To identify these modifications, researchers can employ SEC fractionation followed by LC-MS/MS peptide mapping as described in current methodologies . In this approach:

• The antibody is mixed with its target protein

• The mixture is fractionated by SEC into bound and unbound antibody fractions

• Each fraction undergoes LC-MS/MS peptide mapping to identify and quantify modifications

• Modifications more abundant in the unbound fraction are likely critical quality attributes affecting binding

This approach enables researchers to distinguish between modifications that affect function and those that don't, allowing for improved antibody quality control and experimental design.

How can size exclusion chromatography (SEC) be optimized for SEC10 antibody quality assessment?

Size exclusion chromatography represents a powerful analytical technique for assessing SEC10 antibody quality and functional characteristics. For optimal SEC analysis of SEC10 antibody, researchers should consider the following methodological approach:

• Column selection: Utilize columns with appropriate pore sizes for antibody analysis (typically 300Å). Superose 6 or Superdex 200 columns are commonly used for antibody quality assessment.

• Buffer optimization: Phosphate buffered saline (PBS) at physiological pH (7.2-7.4) is generally suitable for initial analysis, but buffer composition should be optimized based on the specific experimental goals:

  • For stability assessment: PBS with or without low concentrations of non-ionic detergents

  • For binding studies: Buffers mimicking physiological conditions

  • For detection of aggregates: Addition of arginine may help reduce non-specific column interactions

• Sample preparation: Filter samples through 0.22 μm filters prior to injection to remove particulates that might damage the column or produce artifacts.

• Detection methods:

  • UV detection (280 nm) for protein concentration

  • Multi-angle light scattering (MALS) for absolute molecular weight determination

  • Fluorescence detection for labeled antibodies

• Binding assessment: For functional analysis, researchers can mix SEC10 antibody with its target protein at different ratios (e.g., 1:1, 1:2) to assess complex formation and binding affinity . Unbound antibody in a competitive binding environment indicates potential quality issues.

• Fraction collection: Collect bound and unbound antibody fractions for further analysis by orthogonal methods like charge exchange chromatography or peptide mapping to identify modifications affecting binding .

By applying these methodological considerations, researchers can gain comprehensive insights into SEC10 antibody quality, homogeneity, and functional characteristics.

What are the optimal validation approaches to ensure SEC10 antibody specificity?

Validating antibody specificity is crucial for ensuring experimental reproducibility and reliability. For SEC10 antibody, researchers should implement a multi-layered validation strategy:

• Genetic validation:

  • Test antibody reactivity in SEC10 knockout/knockdown models

  • Use CRISPR-Cas9 generated knockout cell lines as definitive negative controls

  • Overexpression systems comparing wild-type and SEC10-overexpressing cells

• Peptide competition assays:

  • Pre-incubate the antibody with purified SEC10 protein or immunizing peptide

  • Compare staining/binding patterns with and without competition

  • Specific antibodies show significantly reduced signal with competition

• Cross-species reactivity testing:

  • Test across multiple species (human, mouse, rat) to confirm conservation of epitope recognition

  • Align sequences across species to predict conservation and potential cross-reactivity

• Orthogonal detection methods:

  • Confirm results using multiple antibodies targeting different SEC10 epitopes

  • Validate with orthogonal techniques (e.g., mass spectrometry, RNA-level detection)

  • Compare results from different antibody clones or sources

• Application-specific validation:

  • For western blotting: Confirm expected molecular weight (77 kDa) and band pattern

  • For immunoprecipitation: Verify pulled-down proteins by mass spectrometry

  • For immunofluorescence: Compare with known subcellular localization patterns

What are common challenges in SEC10 antibody immunoprecipitation experiments and how can they be addressed?

Immunoprecipitation (IP) with SEC10 antibodies can present several challenges. Here are methodological solutions to common issues:

• Low IP efficiency:

  • Increase antibody amount incrementally from 1-5 μg per sample

  • Pre-clear lysates with protein A/G beads to reduce non-specific binding

  • Optimize lysis buffer composition (consider NP-40, CHAPS, or digitonin-based buffers)

  • Use crosslinking agents like DSP (dithiobis(succinimidyl propionate)) to stabilize interactions

• High background:

  • Increase washing stringency gradually (higher salt concentration, low concentrations of SDS)

  • Use conjugated agarose beads (SEC10 Antibody AC format) to eliminate secondary antibody signals

  • Include competing proteins (BSA, non-fat dry milk) in wash buffers

  • Consider using HRP-conjugated TrueBlot® secondary antibodies that preferentially detect non-denatured antibodies

• Co-IP partner detection challenges:

  • Use gentle elution conditions to maintain complex integrity

  • Consider on-bead digestion for mass spectrometry analysis

  • For western blotting detection of partners, optimize SDS-PAGE conditions based on target size

• Reproducibility issues:

  • Standardize cell lysis conditions (cell density, lysis time, temperature)

  • Maintain consistent antibody-to-lysate ratios across experiments

  • Document batch-to-batch antibody variations and compensate accordingly

By systematically addressing these common challenges, researchers can optimize SEC10 antibody immunoprecipitation protocols for high specificity and reproducibility.

How can researchers optimize SEC10 antibody performance in different experimental conditions?

Optimizing SEC10 antibody performance requires methodical adjustment of multiple parameters based on the specific experimental application:

• Western Blotting Optimization:

  • Titrate antibody concentration (typically starting at 1:500 dilution for 200 μg/ml stocks)

  • Test multiple blocking agents (BSA, non-fat dry milk, commercial blockers)

  • Optimize incubation time and temperature (4°C overnight vs. room temperature for 1-2 hours)

  • Consider enhanced detection systems (HRP-conjugated SEC10 antibody eliminates secondary antibody step)

  • For phosphorylated targets, use phosphatase inhibitors throughout

• Immunofluorescence Optimization:

  • Compare different fixation methods (paraformaldehyde, methanol, acetone)

  • Test permeabilization agents (Triton X-100, saponin, digitonin)

  • Optimize antigen retrieval methods if necessary

  • Use directly conjugated antibodies (FITC, PE, Alexa Fluor formats) to reduce background

  • Test incubation temperatures (4°C vs. room temperature)

• Flow Cytometry Optimization:

  • Adjust cell concentration (typically 1×10⁶ cells/100 μl)

  • Optimize fixation/permeabilization for intracellular staining

  • Titrate antibody to determine optimal signal-to-noise ratio

  • Include proper compensation controls for multicolor experiments

  • Select appropriate conjugates based on instrument capabilities

• ELISA Optimization:

  • Test different coating buffers and concentrations

  • Determine optimal blocking conditions

  • Establish standard curves with recombinant SEC10 protein

  • Optimize sample dilutions to ensure readings fall within linear range

  • Consider sandwich ELISA formats for complex samples

For all applications, researchers should perform temperature stability tests to ensure antibody functionality is maintained throughout the experimental workflow.

What advanced techniques can be used to study SEC10 using antibody-based approaches?

Researchers can employ several cutting-edge techniques to gain deeper insights into SEC10 biology:

• Proximity Ligation Assay (PLA):

  • Combines SEC10 antibody with antibodies against potential interaction partners

  • Enables visualization of protein-protein interactions with <40 nm proximity

  • Provides spatial resolution of interactions in fixed cells

  • Quantifiable by counting interaction spots per cell

• STORM/PALM Super-resolution Microscopy:

  • Utilizes fluorophore-conjugated SEC10 antibodies

  • Achieves nanoscale resolution (~20 nm) of SEC10 localization

  • Enables detailed mapping of SEC10 distribution relative to membrane compartments

  • Requires specialized microscopy equipment and analysis software

• SEC-seq for Secretome Analysis:

  • Links secreted products to surface markers and transcriptomes

  • Uses hydrogel nanovials to capture secretions near cells

  • Can be adapted to study SEC10's role in secretory pathways

  • Provides connection between genotype and secretory phenotype

• ChIP-seq with SEC10 Antibody:

  • Investigates potential nuclear roles or transcriptional regulation

  • Maps genomic binding sites if SEC10 has chromatin association

  • Requires optimization of crosslinking and sonication conditions

  • Data analysis involves peak calling and motif analysis

• Live-cell Antibody Fragment Imaging:

  • Uses antibody-derived Fab fragments conjugated to bright fluorophores

  • Enables real-time tracking of SEC10 dynamics in living cells

  • Requires antibody fragmentation and optimization of labeling conditions

  • Minimizes interference with protein function compared to full antibodies

These advanced techniques extend beyond conventional applications and allow researchers to address complex questions about SEC10 localization, dynamics, interactions, and functions with unprecedented detail and precision.

How can researchers assess and improve the stability of SEC10 antibodies for long-term studies?

Ensuring antibody stability is crucial for experimental reproducibility, especially in longitudinal studies. Researchers can employ several methodological approaches to assess and enhance SEC10 antibody stability:

• Stability assessment methods:

  • Size exclusion chromatography (SEC) to monitor aggregation over time

  • Differential scanning calorimetry (DSC) to determine thermal stability

  • ELISA-based activity assays to confirm binding capacity retention

  • SDS-PAGE under non-reducing conditions to detect fragmentation

• Stability-enhancing storage conditions:

  • Store aliquoted antibody at -80°C for long-term storage

  • For working solutions, maintain at 4°C with antimicrobial preservatives

  • Avoid repeated freeze-thaw cycles (limit to <5 cycles)

  • Store in appropriate buffer conditions (typically PBS with stabilizers)

• Formulation optimization:

  • Addition of stabilizers (0.1% BSA, 5-10% glycerol, trehalose)

  • Inclusion of antioxidants to prevent oxidative damage

  • Optimal pH maintenance (typically pH 7.2-7.4)

  • Protection from light (especially for fluorophore-conjugated antibodies)

• Computational design strategies for improved stability:

  • Sequence analysis to identify potential degradation hotspots

  • Rational engineering to modify antibodies for enhanced stability

  • Heuristic sequence analysis for systematic modification

  • Biophysical methods to confirm improved stability of modified antibodies

• Stress testing protocols:

  • Accelerated stability studies at elevated temperatures

  • pH stress tests (pH 4.0-9.0)

  • Mechanical stress (agitation, vortexing)

  • Freeze-thaw cycling effects

Implementation of quality-by-design (QbD) approaches early in research can help identify and address stability issues before they impact experimental outcomes . For critical applications, researchers should establish regular testing intervals to confirm antibody functionality throughout the study duration.

What methods are most effective for determining SEC10 antibody concentration and quality?

Accurate determination of antibody concentration and quality is essential for experimental reproducibility. For SEC10 antibody, researchers should consider these methodological approaches:

• Concentration determination methods:

  • UV spectrophotometry (A280) using extinction coefficient ε = 1.4 for 1 mg/ml IgG

  • Micro BCA or Bradford assays for higher sensitivity

  • ELISA with known standards for absolute quantification

  • Comparison with optical density standards via SDS-PAGE

• Quality assessment techniques:

  • Size exclusion chromatography (SEC) to assess monomer percentage and aggregation

  • SDS-PAGE under reducing and non-reducing conditions to evaluate fragmentation

  • Isoelectric focusing to determine charge heterogeneity

  • Binding activity assays to confirm functional titer

• Advanced characterization methods:

  • LC-MS/MS peptide mapping to identify post-translational modifications

  • Differential scanning calorimetry (DSC) to determine thermal stability

  • Surface plasmon resonance (SPR) to measure binding kinetics and affinity

  • SEC with multi-angle light scattering (SEC-MALS) for absolute molecular weight determination

• Functional validation:

  • Target binding ELISA with recombinant SEC10 protein

  • Immunoprecipitation efficiency testing

  • Western blot against known positive controls

  • Comparison with reference standard antibodies

For comprehensive assessment, researchers should establish acceptance criteria for each quality attribute based on experimental requirements. For critical applications, orthogonal methods should be employed to confirm results from multiple analytical perspectives.

How do different chemical modifications impact SEC10 antibody functionality and detection?

Chemical modifications can significantly affect antibody performance. Understanding these impacts enables researchers to design better experiments and troubleshoot issues:

As demonstrated in research using SEC fractionation followed by LC-MS/MS peptide mapping, analysis of bound versus unbound antibody fractions can identify which modifications critically affect functionality . This approach revealed that modifications affecting binding are significantly more abundant in unbound antibody fractions, providing a powerful method to differentiate critical from non-critical modifications.

Researchers working with SEC10 antibody should consider implementing similar analytical strategies when experiencing unexplained variations in antibody performance, particularly for long-term studies or when working with stressed or aged antibody preparations.

How can SEC10 antibody be used to investigate vesicular trafficking dynamics in different cellular contexts?

SEC10 antibody provides a valuable tool for studying vesicular trafficking dynamics across various cellular systems. Researchers can implement these methodological approaches:

• Live-cell imaging approaches:

  • Microinjection of fluorescently-labeled SEC10 antibody fragments

  • Correlation with fluorescently-tagged vesicle markers (Rab GTPases)

  • FRAP (Fluorescence Recovery After Photobleaching) to measure turnover rates

  • Dual-color imaging to track SEC10 relative to cargo proteins

• Stimulus-response studies:

  • Acute stimulation of exocytosis (calcium ionophores, secretagogues)

  • Temporal immunofluorescence to capture SEC10 redistribution

  • Quantitative western blotting of membrane fractions

  • Co-immunoprecipitation under stimulated vs. basal conditions

• Pathological context investigations:

  • Comparison of SEC10 localization in normal vs. disease models

  • Analysis of SEC10 interactions in neurodegenerative conditions

  • Assessment of trafficking in cancer cells with altered secretory phenotypes

  • Correlation with SEC-seq data to link transcript profiles to secretory function

• Tissue-specific trafficking analysis:

  • Immunohistochemistry with SEC10 antibody across tissues

  • Co-staining with tissue-specific vesicle markers

  • Quantitative analysis of colocalization coefficients

  • 3D reconstruction of trafficking pathways in tissue contexts

When studying disease models, researchers should consider implementing the SEC-seq technique, which links secretory phenotypes to transcriptomic profiles and surface markers . This approach can reveal how SEC10-mediated trafficking pathways are altered in pathological states and identify potential compensatory mechanisms.

What are the latest developments in using SEC10 antibody for studying the exocyst complex in disease models?

The exocyst complex plays crucial roles in multiple cellular processes, making SEC10 antibody an important tool for investigating disease mechanisms:

• Neurodegenerative disease applications:

  • SEC10 antibody immunostaining reveals altered exocyst localization in Alzheimer's models

  • Quantitative analysis of SEC10 levels in brain regions affected by neurodegeneration

  • Co-immunoprecipitation to identify disrupted interactions in Parkinson's disease models

  • Correlation between exocyst dysfunction and synaptic protein trafficking defects

• Cancer research applications:

  • Analysis of SEC10 expression patterns across tumor grades

  • Investigation of exocyst complex involvement in invadopodia formation

  • Correlation between SEC10 localization and metastatic potential

  • Identification of cancer-specific SEC10 interacting partners

• Metabolic disorder investigations:

  • SEC10 antibody-based tracking of GLUT4 transporter trafficking in diabetes models

  • Evaluation of insulin-stimulated exocyst complex formation

  • Analysis of exocyst complex composition in obesity models

  • Correlation with metabolic parameters and insulin sensitivity

• Immune dysfunction studies:

  • Assessment of SEC10 roles in immune cell secretory functions

  • Investigation of exocyst involvement in cytokine release

  • Analysis of SEC10 dynamics during immune cell activation

  • Application of SEC-seq to link SEC10 function to antibody secretion in B cells

Emerging research suggests that targeting the exocyst complex, including SEC10, may represent a novel therapeutic approach for diseases with secretory pathway dysregulation. Researchers can employ SEC10 antibodies not only for basic mechanistic studies but also for validating potential targeting strategies and assessing their impact on exocyst function in disease contexts.